SEC Form 4 · accession 0001209191-15-007238
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert C. Fletcher
Officer — Sr. VP, Bus. Dev. & Strategy
Period of report
Jan 26, 2015
Accepted (ET)
Jan 28, 2015 · 8:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $4.67 | Jan 26, 2015 | A | 600,000 | A | — | Jan 26, 2025 | Common Stock | 600,000 | 600,000 | D |
Explanation of responses
- F1The option vests with respect to 25% of the underlying shares on the first anniversary of the date of grant and the balance of the underlying shares vests in twelve equal quarterly installments following the first anniversary of the date of grant.